About this Program: The Research Team

Stephen Van Den Eeden, PhD

Stephen Van Den Eeden, PhD is an epidemiologist at the Division of Research (DOR), Kaiser Permanente Northern California. He also holds a position as Lecturer in the Department of Health Research and Policy, Stanford University School of Medicine.

Dr. Van Den Eeden's current research efforts are primarily focused on the epidemiology of environmental exposures, neurodegenerative diseases, cancer (with a focus on prostate and pancreatic cancer), and benign genitourinary conditions (e.g., benign prostatic hyperplasia, lower urinary tract symptoms, erectile dysfunction, and urinary incontinence).

Environmental studies have included examining the effect of ambient air pollution and cardiovascular diseases, asthma, and chronic obstructive pulmonary disease using time-series and case-crossover approaches. These studies were funded by the US EPA, the California Air Resources Board, the South Coast Air Quality Management District, and Kaiser Foundation Research Institute.

Dr. Van Den Eeden is an Investigator on studies focused on environmental and genetic risks in neurodegenerative diseases, including Parkinson's disease and amyotrophic lateral sclerosis, or Lou Gehrig's disease. He is also collaborating on epidemiologic studies of restless legs syndrome and dystonia.

In addition, Dr. Van Den Eeden has a suite of studies looking at various aspects of prostate cancer, including a collaborative case-control study to evaluate the efficacy of prostate-specific antigen (PSA) screening in reducing prostate cancer mortality, the validity of self-reported data on screening for prostate cancer, a study of the secular trends in the use of PSA and prostate cancer incidence and mortality, and a study of molecular markers of prostrate cancer survival. He is also a Co-Investigator on the California Men's Health Study cohort funded by the California Cancer Research Program, which is a prospective cohort study of over 84,000 men.

His research in benign genitourinary conditions include studies of the effect of diabetes on benign prostatic hyperplasia (BPH), lower urinary tract symptoms (LUTS), and erectile dysfunction (ED). Other studies include investigating parturition factors and risk of urinary incontinence and prolapse in women.